Table 2. Hazard Ratios Per 1 SD Increment (95% CI) of Cancer Incidence of UA, Albumin, and Total Bilirubin.
UA | Albumin | Total bilirubin | |||||
---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 1 | Model 2 | Model 1 | Model 2 | ||
Cancer incidence (n=1619) | 1.05 (1.02–1.11) | 1.04 (1.01–1.09) | 0.92 (0.88–0.96) | 0.92 (0.88–0.96) | 0.95 (0.90–1.00) | 0.96 (0.91–1.01) | |
Stomach (n=298) | 0.94 (0.83–1.07) | 0.92 (0.81–1.05) | 1.01 (0.90–1.13) | 0.97 (0.87–1.09) | 0.95 (0.85–1.07) | 0.96 (0.86–1.08) | |
CRC (n=238) | 1.11 (0.98–1.27) | 1.08 (0.94–1.23) | 1.03 (0.91–1.17) | 0.99 (0.87–1.13) | 0.95 (0.83–1.08) | 0.96 (0.84–1.09) | |
Lung (n=231) | 0.91 (0.79–1.04) | 0.93 (0.81–1.07) | 0.82 (0.73–0.92) | 0.81 (0.73–0.91) | 0.85 (0.73–0.98) | 0.88 (0.77–1.02) | |
Thyroid (n=135) | 1.03 (0.84–1.28) | 0.97 (0.78–1.22) | 0.99 (0.83–1.17) | 1.06 (0.88–1.27) | 0.99 (0.81–1.20) | 0.98 (0.80–1.19) | |
Prostate (n=116) | 1.36 (1.15–1.60) | 1.33 (1.12–1.59) | 1.07 (0.89–1.28) | 1.08 (0.90–1.30) | 0.96 (0.81–1.15) | 0.95 (0.80–1.14) | |
Liver (n=95) | 1.07 (0.87–1.33) | 1.05 (0.84–1.30) | 0.67 (0.61–0.73) | 0.65 (0.59–0.72) | 1.24 (1.11–1.38) | 1.23 (1.11–1.37) | |
Breast (n=52) | 1.00 (0.70–1.43) | 0.92 (0.63–1.35) | 1.12 (0.84–1.48) | 1.11 (0.82–1.49) | 1.21 (0.96–1.53) | 1.16 (0.89–1.52) | |
Others (n=454) | 1.12 (1.02–1.24) | 1.11 (1.00–1.22) | 1.00 (0.91–1.10) | 0.98 (0.89–1.07) | 0.86 (0.77–0.95) | 0.86 (0.78–0.96) | |
Cancer death (n=617) | 1.02 (0.94–1.11) | 1.03 (0.95–1.12) | 0.88 (0.82–0.95) | 0.86 (0.80–0.93) | 0.89 (0.81–0.97) | 0.91 (0.83–0.99) |
SD, standard deviation; CI, confidence interval; UA, uric acid; N, number of cancer incidence or deaths; CRC, colorectal cancer.
Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, smoking, alcohol drinking, physical activity, education levels, body mass index, family history of diabetes, and serum high density lipoprotein cholesterol levels.